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The essential oil extracted from Cinnamomum verum leaves has been used as an antibacterial and 
antifungal agents for centuries. The objective of this research was to evaluate the antifungal 
activity of the C. verum leaf oil against standard strains of C. albicans (ATCC MYA-2876), C. 
tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646). Effect of C. verum leaf oil in vapor 
phase was evaluated using microatmosphere technique.  CLSI M27-A3 broth microdilution was 
employed in determining MIC and MFC. Time requires to kill planktonic Candida cells, effect on 
initial adhesion and on germ tube formation were evaluated using standard protocols. Effect of C. 
verum leaf oil on forming biofilm was quantified using XTT viability assay, visualized using 
Scanning Electron Microscope (SEM) and the biofilm progression in the presence of essential oil 
was visualized using Time lapses microscope. Effect of Cinnamon leaf oil on established biofilms 
of test strains were quantified and visualized using XTT viability and SEM respectively. Post 
exposure intracellular changes were visualized using Transmission Electron Microscopy (TEM). 
Toxicological assessments were carried out with Human Keratinocyte cell line (HaCaT) and 
Galleria mellonella larvae animal model. Commercial antifungal agent Chlorhexidine digluconate 
was used as positive control. All experiments were done in triplicates. Multiple means of more 
than three data sets were compared using one way ANOVA and two way ANOVA. The level of 
significance was taken at 5% (p < 0.05). Eugenol was the most abundant chemical compound in 
Cinnamon leaf oil. All test strains were susceptible for C. verum leaf oil vapor. C. verum leaf oil 
exhibited MIC value 1.0 mg/ml and MFC value 2.0 mg/ml against all test strains while 
Chlorhexidine exhibited MIC value of 1.0 mg/ml and MFC, 2.0 mg/ml with C. albicans and C. 
dubliniensis. MIC and MFC for C. tropicalis with Chlorhexidine was 0.5 mg/ml.  Killing time of 
Cinnamon leaf oil for C. albicans was 6h. 50% reduction in initial adhesion was achieved with 1.0 
mg/ml, > 2.0 mg/ml and 0.34 mg/ml by C. albicans, C. tropicalis and C. dubliniensis respectively. 
0.5 And 1.0 mg/ml significantly inhibit the germ tube formation of C. albicans and C. dubliniensis. 
Minimum Biofilm Inhibitory Concentration (MBIC50) for forming and established biofilms were 
<0.2 mg/ml for all test strains. C. verum leaf oil caused retardation in biofilm development. SEM 
images exhibited cell wall damages, cellular shrinkages and decreased hyphal formation of 
Candida. TEM indicated intracellular vacuolation, cell wall damages and cytoplasmic granulation. 
Cinnamon leaf oil caused no inhibition of HaCaT cell at maximum concentration tested (1000 
mg/ml). Essential oil of Cinnamon leaf didn’t exhibit a lethal effect at any concentration tested on 
G. mellonella in vivo assay. C. verum leaf oil is a potential alternative anti-Candida agent with 
minimal toxicity. 
 







O óleo essencial extraído das folhas de Cinnamomum verum tem sido usado a tempos como 
um promissor agente antibacteriano e antifúngico. O objetivo desta pesquisa foi avaliar a atividade 
antifúngica do óleo essencial das folhas de C. verum contra cepas padrão de C. albicans (ATCC 
MYA-2876), C. tropicalis (ATCC 750) e C. dubliniensis (ATCC MYA-646). O efeito do óleo 
essencial C. verum na fase de vapor foi avaliado pela técnica da microatmosfera. A microdiluição 
em caldo foi empregada na determinação da CIM e MFC segundo protocolo CLSI M27-A3. O 
tempo necessário para agir sobre a Candida spp. planctônica, o efeito na adesão inicial e a 
formação do tubo germinativo foram avaliados usando protocolos padrão. O efeito do óleo 
essencial de C. verum na formação do biofilme foi quantificado usando o ensaio de viabilidade 
XTT, visualizado por Microscopia Eletrônica de Varredura (MEV) e a progressão do biofilme na 
presença do óleo essencial foi visualizada no microscópio Time Lapse. O efeito do óleo essencial 
de C. verum nos biofilmes formados foi quantificado por teste de viabilidade XTT e MEV, 
respectivamente. Alterações intracelulares pós-exposição foram visualizadas usando Microscopia 
Eletrônica de Transmissão (MET). As avaliações toxicológicas foram levadas a efeito com a linha 
de células de queratinócitos humanos (HaCaT) e larvas de Galleria mellonella. Antifúngico 
comercial e digluconato de clorexidina foi utilizado como controle positivo. Todos os testes foram 
realizados em triplicatas. Múltiplas médias de mais de três conjuntos de dados foram comparadas 
usando ANOVA unidirecional e ANOVA bidirecional. O nível de significância adotado foi de 5% 
(p <0,05). Com as análises de CG o Eugenol foi o composto químico mais abundante presente no 
óleo comercial das folhas de C. verum. Todas as linhagens de teste foram susceptíveis ao vapor do 
óleo das folhas de C. verum. O óleo essencial de C. verum exibiu valor de MIC 1,0 mg/ml e valor 
de MFC 2,0 mg/ml contra todas as cepas de teste, enquanto a clorexidina exibiu valor de MIC de 
1,0 mg ml e MFC, 2,0 mg/ml com C. albicans e C. dubliniensis. A CIM e a MFC para C. tropicalis 
com Clorexidina foram de 0,5 mg/ml. Foi observada uma redução de 50% na adesão inicial com 
1,0 mg/ml,> 2,0 mg/ml e 0,34 mg/ml para C. albicans, C. tropicalis e C. dubliniensis, 
respectivamente. 0,5 e 1,0 mg/ml inibe significativamente a formação de tubos germinativos de C. 
albicans e C. dubliniensis. A concentração mínima inibidora de biofilme em formação (MBIC50) 
e biofilmes estabelecidos foi <0,2 mg/ml para todas as cepas de teste. O óleo da folha de C. verum 
demonstrou inibicão no desenvolvimento do biofilme. As imagens SEM exibiram alterações 
morfologicas na parede celular, encolhimento celular e diminuição da formação de hifas de 
Candida. Nas imagens de MET foram observados vacuolação intracelular, dano na parede celular 
e granulação citoplasmática. O óleo essencial da folha de canela causou inibição de 5% da célula 
HaCaT na concentração máxima testada (1000 mg/ml). O óleo essencial de C. verum não 
apresentou efeito tóxico nas concentrações de 500 mg/ml no ensaio in vivo de larvas de G. 
mellonella. O óleo da folha de C. verum se mostra um potencial agente antifúngico alternativo com 
toxicidade baixa. 
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Biofilms are communities of microorganisms attached to a surface living in a matrix 
of extracellular material derived both from the cells themselves and from the environment. Those 
microorganisms are usually organized into a three-dimensional structure (Acker et al., 2014; 
Marsh, 1999) in order to form this complex biofilm eco system. There are two types of biofilms; 
Monospecies biofilm that involves one microbial species and Multispecies biofilms that involves 
more than one species (Yang, 2003). According to the species involved in formation of biofilms; 
the structure, properties, their sensitivity to anti microbial agents and metabolic activities can vary 
from one biofilm to another. 
Many human microbial infections (more than 65%) (Pierce et al., 2008) involve in 
biofilm formation on implanted biomaterials and/or host surfaces  (Ramage et al., 2005, 
Weerasekera et al., 2016). Among the medically important biofilms, dental plaque (Marsh, 2006) 
is a widely studied biofilm which is known to associate with many oral and non-oral infections 
such as periodontitis (Zijnge, 2010), dental caries (Marsh, 1999) and endocarditis (Nomura et al., 
2006). Dental plaque is a structurally and functionally organized biofilm found on a oral surfaces, 
embedded in a matrix of polymers of host and microorganisms origin (Marsh, 2006). Dental plaque 
consists of more than 1000 different microbial species, where 50% are reported to be uncultivable 
(Runarsson, 2009). Opportunistic pathogens such as Candida species, pathogens such as 
Streptococcus spp. (S. mutans, S. mitis etc.), Lactobacillus spp. and Actinomyces spp. are some of 
these microbial species. 
Candida spp. Is present in various sites of the human body and can causes many other 
non-oral infections and infections associated with medical devices. Systaemic Candidosis, 
Superficial Candida skin infections, ear infections, genitourinary tract infections, Central venous 
catheters, prosthetic heart valves and urinary catheters associated infections are some examples 
(Kojic et al., 2014; Achkar, 2010; Douglas, 2002 and Odds, 1987). Some of these infections are 
serious life threatning infections while some are non-invasive, non-life threatning infections. 
Candida albicans has a greater capacity to form biofilms among other fungal species 
(Ramage et al., 2005 and Kuhn, 2002). In oral cavity Candida spp. play a major role in dental 





(Marsh 1999). Further as diabetes mellitus (DM) is now considered as global epidemic and become 
the number one non communicable disease in all over the worls, we are at risk of acquiring the 
disease (Weerasekera et al., 2017). Candida sessile cells offer greater resistance to antifungal 
treatments compared to its’ planktonic free living counterpart (Pierce et al., 2008).  
Same as oral infections, C. albicans is the most commenly isolated and most virulent 
species of Candida (Weerasekera et al., 2016) responsible for non-oral Candida infections 
followed by C. tropicalis and C. dubliniensis.  
Biofilm formation is initiated with adhesion of microbial cells to host surfaces. 
Candida spp. being more virulent opportunistic yeast, possesses several virulent factors such as 
high ability to adhere to host surfaces, proteinases (enzyme) secretion, hyphal formation, 
phenotypic switching, germ tube formation (C. albicans and C. dubliniensis) and aldehyde 
production (Ramage et al., 2005; Yang, 2003) etc.  
Other than microbial factors, Environmental and host factors can influence the biofilm 
activity of an organism. Dietary nutrients (sugars) (Marsh, 2006 and Jin, 2004), saliva flow (Jin, 
2004), pH of the environment (Marsh, 2006), oxygen supply and temperature (Marsh, 1999)   are 
some of environmental factors and host immune status (HIV) and diseases (diabetes) (Ramage, 
2001) condition are some of host factors which can affect the biofilm formation of a given 
organism. 
Therefore it is very important to conduct studies with regard to Candida biofilm 
formation. This will help to understand its properties, role in infections and to investigate possible 
mechanisms which minimize the oral colonization of Candida spp.  
Since, biofilm structure acts as a protective shiled, routine antimicrobial agents or 
physical stress have less effect on biofilm eradication. So it is important to introduce alternative 
biofilm controling and eradication strategies in order to treat biofilm infections (Marsh, 1999). 
The use of medicinal plants as a tratment option is an ancient practice as well as 
modern world (Petrovska, 2012). Specially ancient asians including Sri Lankans, Indiand and 
Japanese people used these phytochemicals as their theraapeutic agents. The knowledge acquired 





generations and is used until today. The use of medicinal plants as therapeutic alternatives has 
helped many populations that do not have access to modern treatments and drugs of high cost and 
low availability in modern world, so, the use of plants for the treatment of diseases/infections has 
been empirically employed worldwide. In past few years, with the scientific advance, more 
research were conducted to isolate and introduce new compounds with medicinal properties, 
allowing scientists to find new, effective medicinal compounds with low side effects (Gupta et al., 
2014). 
Scientific studies involving the use of medicinal plants have already contributed to 
obtaining several therapeutic agents used in traditional/Ayurvedic medicine. But still, the scientific 
basis of certain medicinal phytochemicals use specially in Asian traditional/Ayurvedic medicine 
should be further evaluated.  In the Dentistry area, Phytotherapy is already an integrative and 
complementary practice to oral health, and its recognition is a great step to regulate the use and 
performance of the dental professionals in this area (Sinha, 2014). Studies show that oils and 
extracts obtained from medicinal plants were efficient as an anti microbial agent, specially against 
oral colonizers. Another important use of medicinal plants is, the synergistic combination with 
other existing commercial drugs in an attempt to reduce or avoid the side effects of conventional 
medicines (Silva et al., 2010). Some reports in the literature indicate that plant derivatives may 
enhance the efficacy of the traditional drug as well as reduce the side effects. Previous studies 
point out that some essential oils and phytochemical compounds have synergistically improved 
activities with commercial antifungals (Shin et al., 2003; Malongane et al., 2017). 
In this context, Cinnamomum verum/ True Cinnamon, is part of the genus most cited 
in therapeutic microbiological studies, including data from clinical studies of medicinal activity. 
In this sense, this plant has been shown to be of great economic and pharmaceutical-medicinal 
interest. Although, several in vitro microbiological studies with C. verum show antimicrobial 
activities related to many microbial species in the health care area, including those that exhibit 







2. LITERATURE REVIEW 
 
2.1 Oral Cavity 
The oral cavity is considered a complex ecosystem with different ecological conditions 
of distribution of nutrients and different atmospheres, which confers different habitats to the oral 
microorganisms that colonize it. The resident microbiota of the oral cavity is diverse and can 
harbor many species of bacteria, mycoplasmas, fungi and viruses (Marsh & Martin, 2005). 
However, both resident and transient colonizers may undergo variations depending on the 
individual's diet, immune conditions, saliva flow, treatments with antibiotic therapy, as well as 
dental treatments (Marsh & Martin, 2005). Due to the polymicrobial character of the oral 
ecosystem, local infections are usually caused by different types of microorganisms and even the 
interaction of more than one species, such as dental caries, periodontal disease and other fungal 
infections (Jenkinson & Lamont, 2010; Ghannoum et al., 2010). Among these oral colonizers, 
Streptococcus spp, are found in both mucous membranes and dental biofilms. These include: 
Streptococcus gordonii, Streptococcus oralis, Streptococcus mitis, Streptococcus mutans and 
Streptococcus sanguinis (Kreth et al., 2005). The dental biofilm is a complex, polymicrobial 
structure that favors the survival of microorganisms that contribute, due to its relation of 
mutualism, allowing the expression of genes that favor communication between them, the evasion 
of the immune system, as well as the production of a specialized habitat for each microorganism 
present (Kreth et al., 2005).  
 
2.2 Oral biofilm formation 
Oral biofilm formation is a complex and dynamic process. First, pellicles are formed 
on oral surfaces by adsorbing salivary proteins and glycoproteins. This surface conditioning film 
is termed the acquired enamel pellicle. The major components of pellicle are salivary 
glycoproteins, phosphor proteins, lipids and other host molecules.  After the pellicle formation, 
reversibly attached acidogenic microorganisms including Streptococcus mutans (Kolenbrander et 
al., 2010) undergo adhesin-receptor mediated stronger irreversible attachment within a short period 
of time. Oral bacteria generally possess more than one type of adhesin molecules on their surface 





on other microorganisms. The dental biofilm pioneer species modify local ecological conditions 
and further promotes colonization by other species that may lead to diseases, such as caries and 
periodontal diseases (Kolenbrander et al., 2002). Among these Secondary colonizers, Candida 
species considered as a major contributor. 
 
2.3 Candida spp. 
Candida spp. are the most common causative agent of fungal infections, leading to a 
range of serious life-threatening invasive to non-life-threatening mucocutaneous diseases 
including skin and ear infections, genitourinary candidiasis, nasocomial pneumonias, medical 
device associated infections and Candidaemias (Kojic et al., 2014, Achkar 2010, Douglas, 2002 
and Odds, 1987). 
Opportunistic fungal infections caused by Candida yeasts, also called candidiases and 
/ or candidoses, are more frequent infections associated with the compromised immune system. 
Predisposing factors for the infection are: extremes of age, hormonal changes, nutritional 
deficiency, HIV incidence, frequent antimicrobial exposure, chemotherapeutic treatments, 
carbohydrate-rich (glucose) diets, use of prostheses and low immunity (Marsh & Martin, 2005; 
Asmundsdóttir et al., 2009; Samaranayake et al., 2002; Sant'Ana et al., 2002) as host factors.  
According to available statistics, approximately 5–7% of infants develop oral 
candidiasis. Prevalence of oral candidiasis in AIDS patients is around 9–31% and 20% in the 
cancer patients. The oral carriage of candida is reported to be 30–45% in the healthy adults (Patil 
et al., 2015). Though, C. albicans is the frequently isolated organism from oral Candida biofilms, 
C. tropicalis, C. glabrata, C. krusei, C. parapsilosis, C. pseudotropicalis, and C. stellatoidea also 
found as causative agents. Recent studies found that the prevalence of above mentioned non- C. 
albicans Candida (NCAC) species is increasing in past few years. (Williams & Lewis, 2011).  
 
2.4 Virulence of Candida 
Among all Candida species, Candida albicans is the most frequent etiological agent 
in cases of fungal infections, being associated in up to 50% of cases of this disease (Pemán et al., 
2012). This genus has the capacity to adapt and proliferate easily in the environment of the human 





its capacity for morphological transition, between hyphal form and yeast form (Tsang et al., 2012). 
According to Mayer et al. (2013), hyphae and yeast, are involved in the infection process, and the 
yeast, being smaller, is able to disseminate, while the hyphae invades the host tissue by penetrating 
the epithelium with the help of proteinases and phospholipases enzymes, escaping from phagocytic 
cells (Mayer et al., 2013; Raju & Rajappa, 2011; Luo et al., 2013; Coutinho, 2009).  
Another factor associated with virulence of Candida spp. is the ability to form 
biofilms, Promoting cell adhesion and formation of the extracellular matrix of the biofilm, as well 
as the synthesis of proteins that favor its further adhesion. The biofilm structure increases the 
resistance to antimicrobial agents, due to the difficulty of penetration into the extracellular matrix, 
and the action of the immune system, besides allowing the increase of the gene expression of 
mechanisms of resistance to antifungals as the efflux pumps (Santana et al., 2013). 
 
2.4.1 Biofilms and their resistance 
The resistance of biofilms to antimicrobial agents is often attributed to the failure of 
these agents to penetrate the biofilm matrix. Drug access into the biofilms is also assisted by the 
presence of water channels in the biofilm structure. Nevertheless, biofilm extracellular matrix 
components could reduce access to such an extent that cells lying deep within a biofilm escape 
exposure. This would occur through adsorption or neutralization of antimicrobial agent, and would 
depend on the thickness of the biofilm and on the chemical nature of both the antimicrobial agent 
and the extracellular matrix material. For example, fluoroquinolones penetrate P. aeruginosa 
biofilms readily, whereas penetration by positively charged aminoglycosides is decreased. 
Similarly, fluconazole penetrates single-species Candida biofilms more rapidly than flucytosine. 
Further, rates of drug diffusion through biofilms of Candida glabrata or Candida krusei are faster 
than those through biofilms of Candida parapsilosis or Candida tropicalis, while diffusion of 
antimicrobial drugs through mixed-species biofilms of C. albicans and S. epidermidis is 
significantly slow (Drenkard, 2003; Al‐Fattani et al., 2006).  
Since biofilms exhibit greater resistance to antimicrobials compared to suspension 
grown planktonic cells (Pierce et al., 2008), different types of strategies are used in oral biofilm 
control and treatment of oral biofilm infections. Traditional methods of biofilm removal include 





(Soukos et al., 2011). Due to lack of availability, harmful side effects and polymicrobial resistance, 
it’s very important to find new effective alternative antimicrobial strategies in order to control 
these oral biofilm infections. As a result of those studies, many plants and phytochemicals were 
identified as potential anti-biofilm remedies.  
 
2.5 Medicinal plants 
Anti-microbial resistance is an emerging problem in health care facilities in modern 
world.  (CDC, Atlanta, 2013). Resistance of microorganisms against available antimicrobials has 
become a major problem, especially when it comes to infections in immunocompromised patients. 
Such resistance has resulted in a dramatic increase in the incidence of systemic and opportunistic 
microbial infections and mortality, which leads to an increasing need for the development of 
effective new antimicrobial therapeutic drugs. According to published data, pathogens with 
multidrug resistance are methicillin-resistant Staphylococcus aureus (MRSA), a common 
causative agent of nosocomial infections, and which is exhibiting a resistance to vancomycin (Van 
et al., 2013), Pseudomonas aeruginosa (Nathwani et al., 2014), Streptococcus pneumoniae, a 
common respiratory pathogen with multidrug resistance (Kim et al., 2016), multidrug-resistant 
Mycobacterium tuberculosis (Kempker et al., 2015), which are causing an increase in the 
prevalence of tuberculosis; and virulent strains of Escherichia coli (Krüger et al., 2015) 
Azoles are group antifungal drugs used widely as a treatment of Candidiasis since they 
cause few side effects in human body. Resistance to azoles arises during long-term exposure to the 
drug as well as low-level prophylactic treatment regimes (Kontoyiannis et al., 2002) 
Due to this increasing multiresistance of etiological agents, many scientists pay their 
attention to develop new antimicrobial remedies to combat these microorganisms based on 
medicinal plants derivatives with low side effects, lower toxicity and decreased development of 
resistance of microorganisms (Al-Mariri, 2013). 
 Though plants have provided western medicine with an abundance of medicines and 
treatments for a variety of infections, species used in traditional medicines continue to be the most 





plants worldwide are used in traditional medicine as treatments for bacterial and fungal infections. 
But, among these vast range of plants, very few of these have subjected to in vitro screening.  
Further, natural herbal antimicrobial products are not necessarily safer than synthetic 
antibiotics, some patients prefer to use herbal medicines due to various reasons. Thus healthcare 
professionals should be aware of the available evidence for herbal antibiotics in order to ensure 
safe and effective use of those herbal medicines (Karen et al., 2003). 
 
2.6 True Cinnamon/ Ceylon Cinnamon/ Cinnamomum verum 
There are different types of Cinnamon species all over the world. Among them, true 
cinnamon/ ceylon cinnamon/ Cinnamomum verum is native to Sri Lanka and belongs to the family 
Lauraceae.  
Cinnamomum cassia (Chinese Cinnamon), C. burmannii (Indonesian cinnamon), C. 
loureiroi (Vietnamese cinnamon) and C. citriodorum (Malabar cinnamon) are other major 
cinnamon species all over the world (Chen et al., 2014). Though all of them belongs to same genus, 
Cinnamomum, they are exhibiting different physical and chemical properties. 
Cinnamon oil can be extracted from leaves or bark of Cinnamon tree. Based on the 
part of the tree used for extraction, chemical composition of the extracted oil is vastly varying. 
Both cinnamon leaf and bark essential oils contain cinnamaldehyde and Eugenol as their key 
constituents but the leaf oil has higher levels of eugenol, and the bark oil has higher levels of 
cinnamaldehyde. Both contain trace amounts of 43 other chemical compounds including 
bicyclogermacrene, α-phellanderene, ß-carryophyllene, aromadendrene, p-cymene α-copaene, α-
amorphene and 1,8-cineole (Singh et al., 2007). 
 
2.6.1 Cinnamon oil as an antimicrobial agent 
Essential oils are mixtures of various chemical compounds originating from the 
secondary metabolism of plant species, constituting a rich source of biologically active 
compounds. Thus, the novel antifungal drug discovery based on natural herbal products is 





Some publish evidences revealed the potential antimicrobial activity of essential oils 
extracted from Cinnamon plant. For example, Nir et al. (2000) investigated the effect of extract of 
cinnamon (Chinese cinnamon/Cinnamonum cassia) against Helicobacter pylori, Azzouz et al. 
(1982) investigated the effect of Chinese cinnamon against seven mycotoxigenic molds 
Aspergillus flavus, A. parasiticus, A. ochraceus, Penicillium spp. M46, P. roqueforti, P. patulum, 
and P. citrinum and observed growth inhibition of those molds (Nir et al., 2000; Azzouz et al., 
1982).  
Similarly Suksrikarm (1987) reported theantimicrobial activity of Cinnamon oil 
against many microbial species including Lactobacillus spp., Bacillus thermoacidurans, 
Salmonella spp., Corynebacterium michiganense, Pseudomonas striafaciens, Clostridium 
botulinum, Alternaria spp., Aspergillus spp., Canninghamella spp., Fusarium spp., Mucor spp., 
and Penicillium spp. (Suksrikarm, 1987). 
Further, Singh et al. (2007) demonstrated the antifungal effect of Cinnamon oil against 
pathogenic fungi, Aspergillus niger, Aspergillus flavus, Aspergillus ochraceus, Aspergillus 
terreus, Fusarium moniliforme, Fusarium graminearum, Penicillium citrinum and Penicillium 
viridicatum (Singh et al., 2007). 
While the in vitro antimicrobial activity of Cinnamon oil against some pathogens have 
well documented, there are lack of published data for anti-Candida activity of Cinnamon oil. In 
















2.7 Conceptual Framework 
Conceptual framework for Biofilm formation of Candida species: Effect of True cinnamon (C. 




































































3.1. General Objective 
To evaluate the anti-biofilm effect against in vitro Candida biofilms and the cytotoxic effect of 
true cinnamon (Cinnamomum verum) leaf oil. 
 
3.2. Specific objective 
1. To determine the effect of true cinnamon (Cinnamomum verum) leaf oil on Planktonic 
Candida. 
2. To determine the effect of Cinnamomum verum leaf oil on initial adhesion and germ tube 
formation of Candida. 
3. To determine the effect of true cinnamon (Cinnamomum verum) leaf oil on forming and 
established in vitro Candida biofilms. 
4. To determine the post-exposure structural changes of Candida in vitro biofilms.  
5. To determine the cytotoxic effect of true cinnamon (Cinnamomum verum) leaf oil on human 
keratinocyte (HaCaT) cell line. 
















4. MATERIAL AND METHODS 
 
4.1.  Study design 
The study was an experimental laboratory based study. 
4.2.  Study setting 
The study was conducted in Microbiology and Immunology laboratory of the Area of 
Microbiology and Immunology, Department of Oral Diagnosic, Piracicaba Dental School, 
University of Campinas, Brazil. 
Address for correspondance: Piracicaba Dental School – UNICAMP, Area of 
Microbiology and Immunology, Limeira Avenue, 901. CEP:13414- 018, Piracicaba, SP, Brazil. 
 
4.3.  Essential oil 
Commercially available essential oil of C. verum leaf was purchased for this study. 
 
4.4.  Dilution of essential oils and antifungals  
 The C. verum essential oil was diluted in Tween 80 (0.05%) solution and RPMI 
culture medium (Roswell Park Memorial Institute medium) buffered with MOPS (3-(N-
morpholino) propane sulfonic acid) followed by sonication, 1 cycle of 20 seconds in to the final 
concentration of 32 mg/ml.  
The antifungal Chlorhexidine digluconate (Sigma Aldrich, USA) was diluted in RPMI 
culture medium (Sigma Aldrich, USA) buffered with MOPS according to the manufacturers’ 










4.5.  Gas Chromatography- Mass spectrometry (GC-MS) of C. verum leaf oil 
Analyzes were performed on an HP-6890 gas chromatograph coupled with HP-5975 selective 
mass detector, under the following conditions: 
HP-5MS Capillary Column (30 m x 0.25 mm x 0.25 µm) 
Temperatures: Injector: 220 ° C 
Column: 60 ° C, 3 ° C / min, 240 ° C 
Detector: 250 ° C 
Injected Volume: 1.0 µl 
Carrier Gas Flow (He): 1.0 ml/min 
 
4.6.  Test strains of Candida used in the study 
Three Candida type strains, C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 
750) and C. dubliniensis (ATCC MYA-646) were used in this study. These strains were obtained 
from Microbiology and Immunology Area, Piracicaba Dental School, UNICAMP, Brazil.  
 
4.7.  Stocking and reactivation of test microorganisms 
 
The standard strains of Candida spp. stocks were maintained in 80% grycerol in 
ultrafreezer at -80 °C. To reactivate stock organisms, they were subcultured in freshly prepared 
Saboraud Dextrose Agar (SDA, OXOID) culture medium, incubated aerobically at 37ºC for 24h. 
All the experiments in this study were conducted in triplicate. Further all these 
experiments were conducted with maximum precautions to avoid any environmental 
contamination. The experiments were conducted inside a Class II Biosafety cabinet in the 








4.8. Effect on Planktonic Candida 
 
4.8.1.  Effect of C. verum leaf essential oil in vapour phase (Microatmosphere 
method, Kalemba et al., 2003 and Şerban et al., 2011) 
Effect of C. verum leaf essential oil in vapour phase on planktonic Candida cells were 
qualitatively determined using Microatmosphere method explained by, Kalemba et al. (2003) and 
Şerban et al. (2011) previously with few modifications. 
Standard suspensions of all test strains mentioned in 4.6 were prepared by dissolving 
portion of isolated colony in sterile normal saline by measuring and adjusting the absorbance to 
0.08-0.1 at 600nm (0.5 McFarland standard). 
The prepared suspensions were inoculated separately with a sterile cotton swab on to 
the prepared quality controlled SDA plates separately in order to get a confluent growth.  
A 10 mm diameter sterile filter paper disc moistened with 100 µl of the working 
solution (1.046 g/ml) of essential oil was attached to the lid of a Petri dish. Plates were sealed with 
a piece of parafilm in order to prevent leakages of oil vapour. Agar plates were incubated overnight 
at 37oC aerobically. Control plates were prepared without filter paper disks. 
Presence or absence of growth inhibition of inoculated Candida on agar surface was 
observed after 24h incubation. 
 
4.8.2. Determination of Minimum Inhibitory Concentration (MIC) 
 
4.8.2.1. Preparation of Candida cell suspensions 
Minimum inhibitory concentration (MIC) of Candida was determined by following 
the CLSI M27-A3 broth micro dilution method with modifications (CLSI, 2008). 1×106 cells/ml 
suspensions of all test strains were prepared in sterile RPMI 1640 buffered with MOPS using 24 






4.8.2.2. Preparation of doubling dilutions of antifungal agents and assay 
32 mg/ml mother solution of essential oil was prepared as mentioned in 4.4, 200µl of 
this mother solution was added to first well column and serially diluted with sterile RPMI 1640 
buffered with MOPS, 100µl/well in order to prepare series of doubling dilutions of essential oil 
along the rows of the 96 well sterile flat bottomed microtiter plate.  
Then the plate was inoculated with 100µl of prepared standard cell suspensions 
separately. (Each well received 100μl of the dilutions of the oil and 100μL of the suspension of 
each test strain of Candida spp. at a final concentration of 0.5 x 106 CFU/ml in each well) 
Negative control group (Growth control): 100µl of RPMI 1640 instead of essential oil 
+ standard cell suspension  
Positive control group: 120 mg/ml Chlorhexidine gluconate (Sigma-Aldrich, USA) 
was tested.  
The plates were incubated for 24 h at 37 °C aerobically and were visually examined 
for the presence and absence of growth (turbidity of the suspensions). Three independent 
experiments were performed. 
 
4.8.3. Determination of Minimum Fungicidal Concentration (MFC) 
MIC assay was performed as explained in 4.8.2 and 5 μl of solutions from each well 
(after 24h incubation) were plated in freshly prepared SDA plates and incubated at 37 °C for 24 h 
aerobically. MFC was defined as the lowest concentration of essential oil capable of inhibiting the 
fungal growth completely. 
 
4.8.4. Killing Time Assay 
Time-kill kinetics of leaf oil of C. verum was carried out following the procedure 
described by Tsuji et al. (2008). Concentrations equal to MIC (1mg/ml), half of MIC (0.5mg/ml) 





An inocula of C. albicans (ATCC MYA-2876) were prepared with the concentration 
of 1.0×106 CFU/ml as explained in 4.8.1. and added to prepared dilutions separately. Microtiter 
plates were incubated at 37oC for 24h aerobically.  
Aliquots of 50µl of the above mixture were taken at time intervals of 0, 1, 2, 3, 4, 5, 6, 
12, and 24h, make 10 fold dilutions in 50µl sterile normal saline and 100 µl was spread on SDA 
plates aseptically. Inoculated plates were incubated at 37 ∘C for 24h aerobically to determine 
CFU/ml. Negative control test was performed for the test organisms without oil or reference 
antifungal agent, 120mg/ml Chlorhexidine gluconate. Log CFU/ml was plotted against time (Tsuji 
et al., 2008). 120 mg/ml chlorhexidine gluconate was used as positive control. 
 
4.9.  Effect on Initial Adhesion 
Adhesion to host surfaces is one of the main virulent factor of Candida spp. 
Candida biofilm formation begins with the adhesion of planktonic yeast cells to a surface (biotic 
or abiotic surfaces). The next step in biofilm formation is cell proliferation and early-stage hyphal 
formation of the adhered cells. This step is followed by biofilm maturation, resulting in a complex 
eco-system, including elongated hyphae, pseudohyphae, and budding yeast cells, encased in an 
extracellular matrix, giving the biofilm a thick and structured three dimensional appearance as well 
as providing protection from chemical and physical stresses. 
Effect of C. verum leaf oil on  C. albicans (ATCC MYA-2876), C. dubliniensis 
(ATCC MYA-646) and C. tropicalis (ATCC 750) adhesion to a sterile polystyrene surface was 
studied by using previously published methodology by Raut et al. (2013). 
 
4.9.1. Preparation of standard cell suspension  
Few colonies of 24 hours old fresh Candida cultures on SDA were inoculated into 50 
ml of YPD broth  in labeled sterile culture media bottle and incubated at 35-37 oC for 18-24 hours 
in a shaking incubator at 30rpm (Nova Instruments, Brazil). 
After incubation, cells were harvested and washed twice with sterile Phosphate 
Buffered Saline (PBS) and the inoculum was adjusted to 1.0 x 107 cells/ml in RPMI 1640 medium 





4.9.2. Assay procedure 
96 well sterile flat bottomed microtiter plates were seeded with these suspensions (100 
µl/well) and allowed to adhere to polystyrene surface of plates for 2h at 37 oC in a shaker incubator 
(75 rpm, Nova Instruments, Brazil), in the presence of different concentrations of C. verum leaf 
oil ranging from 8mg/ml to 0.0039mg/ml (100 µl/well). Wells without oil were kept as negative 
control. 120mg/ml chlorhexidine digluconate (Sigma-Aldrich, USA) was used as positive control. 
After 2h incubation, wells were washed with 200 µl sterile normal saline in order to 
remove non-adherent cells. Attached cells in each well were quantified using XTT metabolic assay 
as explained below, and percentage reduction of adhered cells was calculated as compared to that 
of control (Raut et al., 2013).  
 
4.9.3. XTT assay   
For the quantification of biofilm cell viability, the plates were washed with sterile PBS 
and then reacted with 80μL of the XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-
Tetrazolium-5-Carboxanilide, Sigma-Aldrich) and menadione (Sigma-Aldrich) solution (4µl of 
menadione in 10ml XTT) for 2h. Then, the absorbance of resulting solution was measured at 
490nm using microtiter plate reader /Versa MAX, molecular Devices, USA (Pierce et al., 2008). 
 
4.10. Effect on Hyphae Formation (Germ tube) 
Dimorphic fungi including C. albicans and C. dubliniensis have several morphological 
forms; yeast cells (blastoconidia) which divide by budding, germ tubes, true hyphae and 
pseudohyphae. The formation of germ tubes from blastoconidia is the first step in the development 
of true hyphae and the ability to switch between morphological forms has been suggested as a 
potential virulence factor. Compared to the unicellular blastoconidial form, hyphae have an 
increased ability to adhere to and penetrate host tissues.  
An experiment described by Hammer et al. (2000) was carried out to examine the 
effects of true cinnamon leaf oil on the morphological transition (germ tube/hyphal formation) 
from blastoconida to hypha of C. albicans (ATCC MYA-2876) and C. dubliniensis (ATCC MYA-





Three concentrations, 0.25 mg/ml, 0.5 mg/ml and 1.0 mg/ml (1/4 MIC, 1/2 MIC and 
MIC) of C. verum leaf oil and Chlorhexidine digluconate were prepared in Fetal Bovine Serum 
(FBS, Sigma-Aldrich) in 1 ml volumes in sterile glass Bijou bottles at twice the desired final 
concentration as follows: 0.5, 1.0, 2.0 and 0 mg/ml.  
Equal volumes (1 ml) of the prepared cell suspensions in YPD  medium as explained 
in 4.9.1. were added to each C. verum leaf oil treatment and mixed thoroughly. All treatments were 
then incubated aerobically at 37 °C, without shaking, and were sampled at 0h, 2h, 4h and 6h after 
mixing thoroughly.  
10 μl of prepared suspensions were loaded to Neubauer improved counting chamber 
at each time point and percentages of germinated cells (Cells with germ tubes) were calculated by 
counting the cells. 
 
4.11.  Effect on Forming Candida Biofilms 
Biofilm experiments were performed as following, using C. albicans (ATCC MYA-
2876), C. dubliniensis (ATCC MYA-646) and C. tropicalis (ATCC 750) as test strains. 
120 mg/ml chlorhexidine digluconate was used as positive control of the experiment. 
4.11.1.  Effect on biofilm formation  
100μl of standard inoculum of each organism was inoculated to a 96-well sterile flat 
bottomed microplate plate, followed by aerobic incubation for 120 minutes under agitation (75 
rpm at 37 °C)( Nova Instruments, Brazil). The plate was then washed once with sterile Phosphate 
Buffered Saline (PBS) and 100μl of the dilutions of the essential oil (dilutions of essential oil were 
prepared according to 4.8.2.2.) was added to the treatment wells. 100μl of RPMI 1640 was added 
to the control wells instead of oil. The plate was then aerobically incubated for 24h at 37 °C (Silva 
et al. 2010).  
Biofilm biomass was quantified after 24h incubation using XTT metabolic assay 







4.11.2.  Minimum toxic concentration for forming biofilms (MTC) 
Minimum toxic concentration for forming biofilms (MTC) determines the minimum 
concentration of C. verum leaf oil requires to kill the forming biofilms of Candida spp. completely. 
The CFU assay was used to detect the MTC of the oil on forming biofilms. After the 24h treatment 
with different concentrations of C. verum leaf oil, the mass of the adhered biofilm was scraped 
using a sterile cell scraper and thoroughly homogenized in 100µl of sterile normal saline and then 
the suspension was serially diluted (10-1 to 10-6). Subsequently, an aliquot of 100µL was plated on 
SDA medium. Agar plates were incubated at 37ºC for 24h. After incubation, the colony forming 
units were counted and the results were expressed in CFU/ml (Freitas-Fernandes et al. 2014). 
4.11.3.  Scanning Electron Microscopy (SEM) of forming biofilms in the presence of 
C. verum leaf oil 
Ultrastructural properties of biofilms formed with the presence of different 
concentrations of true Cinnamon oil was evaluated using SEM.  
4.11.3.1. Adhesion of Candida  
10mm diameter glass cover slips were autoclaved and sterilized prior to biofilm 
growth. Sterile cover slips were placed in 12-well cell culture cluster separately. Coverslips were 
immersed in 1 ml standardized cell suspension (1x107 cells/ml) to ensure uniform Candida 
adhesion and incubated for 120 min at 37 ˚C in a shaker incubator (Nova Instruments, Brazil).  
4.11.3.2. Biofilm formation and antifungal treatment  
Then the cover slips were moved carefully using a sterile forceps and gently immersed 
in new 12-well plate containing 0.5mg/ml, 1.0mg/ml and 2mg/ml C. verum oil in RPMI 1640 
(1ml/well). Coverslips were incubated aerobically for 24 h at 37˚C.  
4.11.3.3.  SEM procedure 
The cover slips with treated biofilms were subsequently washed three times with sterile 
PBS. Then they were transferred to a new 24-well cell culture cluster containing 2.5% 
glutaraldehyde at 4 ˚C.  
After fixing with glutraldehyde for 60 minutes, samples were dehydrated in a series of 
ethanol solutions (70% for 10 min, 80% for 10 minutes, 95% for 10 min and 10 minutes in absolute 





Then the specimens were mounted on an aluminum stub, with carbon tape, and coated 
with gold under low-pressure with a gold sputter coater (JFC1 100; JEOL). The surface of the 
biofilms were visualized with the SEM (JEOL, JSM 5600LV) in high-vacuum mode at 10 kV, and 
the images processed. 
 
4.11.4.  Biofilm Progression Analysis (Time Lapse Microscopy) 
Progression of Candida in vitro biofilms in the presence of C. verum leaf oil was 
evaluated using using Time Lapse Microscopy. 
For analyzes of biofilm progression in the presence of C. verum leaf oil, C. albicans 
(ATCC MYA-2876); C. dubliniensis (ATCC MYA-646) and C. tropicalis (ATCC 750) were 
adhered on to the polystyrene surface of 24-well cell culture cluster and treated with three 
concentrations (0.5mg/ml, 1.0mg/ml and 2.0 mg/ml) of C. verum leaf oil as explained in 4.9.2. 
During the 24 hour incubation at 37 oC after adding the treatment, images of forming biofilms 
were captured at time 0, 4 h, 8 h, 12 h, 16 h, 20 h and 24 h using time-lapse microscope. (ZEISS 
ApoTome.2) (Oliveira, 2019). 
 
4.12. Effect on Established Candida Biofilms  
 
4.12.1. Minimum Biofilm Inhibitory Concentration (MBIC50 and MBIC75) 
100μl of standard inoculum of each organism was inoculated to a 96-well sterile flat 
bottomed microplate plate, followed by aerobic incubation for 24h at 37˚C. The plate was then 
washed once with sterile Phosphate Buffered Saline (PBS) and 100μl of the dilutions of the 
essential oil (dilutions of essential oil were prepared according to 4.8.2.2.) was added to the 
treatment wells. 100μl of RPMI 1640 was added to the control wells instead of oil. The plate was 
then aerobically incubated for 24h at 37 °C (Pierce et al., 2008).  
Biofilm viability was quantified after 24h incubation using XTT metabolic assay 






4.12.2. Minimum biofilm eradication concentration (MBEC) 
The CFU assay was performed to detect the MBEC of the oil on established 24h mature 
biofilms after the 24h treatment with different concentrations of C. verum leaf oil, as explained in 
4.11.2. After incubation, the colony forming units were counted and the results were expressed in 
CFU/ml. 
                    4.12.3. Ultrastructure of Candida biofilms after 24h exposure to C. verum leaf oil 
Post-exposure architectural properties of Candida 24h mature biofilms after 24h 
treatment with essential oil was evaluated using SEM. 
10mm diameter glass cover slips were autoclaved and sterilized prior to biofilm 
growth. Sterile cover slips were placed in 12-well cell culture cluster separately. Coverslips were 
immersed in 1 ml standardized cell suspension (1x107 cells/ml) and incubated for 24h at 37 ˚C.  
After biofilm formation process, the cover slips were moved carefully using a sterile 
forceps and gently immersed in new 12-well plate containing 1.0mg/ml, 2mg/ml and 4mg/ml C. 
verum oil in RPMI 1640 (1ml/well). Coverslips were incubated aerobically for 24 h at 37˚C.  
SEM procedure was carried out as explained in 4.11.3.3 in order to visualize 
ultrastructure of biofilms. 
 
4.13. Transmission Electron Microscopy (TEM) for Determination of Post-
Exposure cellular Changes 
Antimicrobial agents act on microbial cells differently based on their mode of action. 
Some antimicrobial agents damage the cell wall of unicellular organism by inhibiting cell wall 
synthesis, some antimicrobial agents inhibit protein biosynthesis and some inhibit DNA 
replication. The three major groups of antifungal agents in clinical use, azoles, polyenes, and 
allylamine/thiocarbamates, exhibit their antifungal activity by inhibiting synthesis of major cell 
wall component ergosterol. (Ghannoum et al., 1999 and Kapoor et al., 2017) 
To determine the effect of C. verum leaf oil on Candida cell wall, post exposure 





Briefly, standard cell suspensions with 1×106 cell concentration were prepared in 
RPMI 1640 as explained in 4.8.1. 1 ml of prepared suspensions were mixed with 9 ml of antifungal 
oil dilution in RPMI 1640 with the concentration of 10×MIC (10 mg/ml) separately and incubated 
at 37 oC for 24h aerobically. After incubation, the resulting cell suspension was centrifuged and 
the cell pellet was resuspended with the Karnovsky's fixative for 18-24 hours at 4 °C. After 
fixation, Wash the samples in 3 exchanges of 0.1M Sorensen phosphate buffer (pH 7.2-7.4) for 5 
minutes. Then the samples were fixed with 1% osmium tetroxide. Samples were then air dried at 
room temperature for 2h followed by washing 3 times with 0.1M Sorensen phosphate buffer for 5 
minutes each. Specimens were then dehydrated with increased concentrations of acetone (30%, 
50%, 70%, 90% and 100%) for 5 minutes each. The prepared specimens were then embedded in 
Dr. SPURR resin followed by observation using TEM (JEM-1400, JEOL). 
 
4.14. Effect of C. verum Leaf Oil on Host Tissues  
 
4.14.1. Cytotoxicity of C. verum leaf oil 
The experiments of anti-proliferative activity of true cinnamon leaf oil was carried out 
according to the protocol described by Monks et al. (1991) and Orellana et al. (2016).  
Cellular growth was quantified spectrophotometry by using 3-(4,5-dimethyl2-
thiazolyl)-2,5-diphenyl-2H-terazolium bromide metabolic assay (MTT, Sigma-Aldrich) and 
analysis was based on the in vitro screening method for anticancer drugs conducted by National 
Cancer Institute (NCI, USA) using the panel of 60 human tumor cell lines (NCI60) (Monks et al., 
1991; Shoemaker, 2006). 
4.14.1.1. Cell Line and Culture Medium  
HaCaT (Human Keratinocyte Cell line) cell line obtained from Department of Oral 
Pathology, Faculty of Dentistry in Piracicaba, was used in this study.  
Cells were cultured in RPMI 1640 medium supplemented with 10% Fetal Bovine 
Serum (FBS) and antibiotics, 100 µl/ml penicillin and 100 µg/ml streptomycin (Sigma-Aldrich). 






4.14.1.2. In Vitro Assay for Cytotoxicity 
For testing, cells were washed with sterile phosphate buffer saline (PBS) and harvested 
by tripsinization using 2.5 g/l trypsin in EDTA (Cultilab, Brazil) and counted using Neubauer’s 
improved counting chamber. Cell density was adjusted to 6.5x104 cells/ml. Prepared standard cell 
suspension was plated (100µl/well) in sterile flat bottomed cell culture treated 96 well microtiter 
plates (Kasvi, Brazil) and incubated under 5% CO2 and 95% air at 37
oC for 24 hours. After 
incubation, cell lines were treated with 100µl of different concentrations (8 mg/ml, 4 mg/ml, 2 
mg/ml, 1 mg/ml, 0.5 mg/ml, 0.25 mg/ml, 0.125 mg/ml and 0.0625 mg/ml) of C. verum leaf oil 
diluted in FBS and antibiotic supplemented RPMI 1640 medium for another 24h in same 
incubation conditions. Dilutions of 120 mg/ml (0.12%) chlorhexidine digluconate was used to 
compare the cytotoxicity with true cinnamon leaf oil. Control cells (negative) were incubated with 
culture medium only. All concentrations of leaf oil were in triplicates on the same cell batch. 
4.14.1.3. Quantification of cellular proliferation  
Cell viability/proliferation of HaCaT cell line after exposure to C. verum and 
chlorhexidine digluconate was quantified spectrophotometry by using 3-(4,5-dimethyl2-
thiazolyl)-2,5-diphenyl-2H-terazolium bromide (MTT) metabolic assay. 
After the incubation period, the cell suspensions in each well were aspirated. All wells 
including control wells were filled with 100 µl of 5 mg/ml MTT solution per well. Plates were 
then incubated at 37oC, under an atmosphere of 5% CO2 and 95% air for 4h. After incubation, 
remaining MTT solution was replaced with 100 µl of Dimethyl Sulfoxide (DMSO) per well.  
The spectrophotometric reading of the absorbance was performed at 492 nm using a 
microplate plate reader. With the mean absorbance values for each concentration, the percentage 









4.14.2.  In vivo effect of C. verum essential oil on Galleria mellonella larvae (Minimum 
Lethal Concentration (MLC) 
The in vivo toxicity test was performed on Galleria mellonella larvae as described by 
Scorzoni et al. (2013) with the collaboration of Pharmocology department at Piracicaba dental 
school, UNICAMP.  
Study groups and control group (10 larvae per group/ n=10) of larvae (RJ Mous 
Livebait, The Netherlands) were selected by measuring their body weight (0.2 - 0.3 g larvae were 
included as study population) and selected larvae were placed in Petri dishes (10/petri dish). Larvae 
with color changes in their bodies including dark pigmantations or apparent melanization, were 
excluded. 
Essential oil dilutions of C. verum leaf were prepared with sterile PBS as explained in 
4.4. (1000.0, 500.0, 250.0, 128.0, 64.0, 32.0, 16.0, 2.0, 1.0, 0.5 mg/ml) 
1 µl of essential oil dilutions were injected in the haemocele through the last left pro-
leg of Galleria mellonella larvae using a 1 ml syringe. The pro-leg was decontaminated with 70% 
ethanol prior to administration of oil. Larvae containing petri dishes were then covered with lis 
and placed in an aerobic incubater at 37 °C. 
Mortality of Larvae was monitored by visual inspection of the body colour (brown-
dark brown) and by lack of body movement after touching them with forceps. The experiment was 
repeated twice.  
 
4.15. Statistical analysis 
 
The statistical analysis was carried out by using the software, Statistical Package for 
Social Sciences (SPSS) version 16. Multiple means of more than three data sets were compared 









5.1 Chemical composition of true cinnamon leaf oil 
 
Chromatographic analysis of C. verum leaf essential oil was done using HP-6890 gas 
chromatograph coupled with HP-5975 selective mass detector. Detected chemical constituents and 
their relative abundance were represented in Table 5.1. Chromatogram of the analysis was 
attached in Annex. The most abundant compounds were Eugenol  (77.22%), Benzyl benzoate 
(4.53%), Trans caryophyllene (3.39%), Acetyle eugenol (2.75%) and Linalool (2.11%) (Table 
5.1). 
 Table 5.1: Compounds and relative abondunce of C. verum leaf essential oil detected by GC/MS. 
Retention 
time (min) Compound 
% 
Abundance 
21.41 Eugenol 77.22 
36.65 Benzyl Benzoate 4.53 
23.67 Trans caryophyllene 3.39 
28.03 Acetyl eugenol 2.75 
10.56 Linalool 2.11 
17.45 Trans-Cinnamaldehyde 1.69 
24.71 Acetic acid cinnamyl ester 1.49 
 
5.2  Effect on Planktonic Candida 
 
5.2.1 Effect of C. verum leaf essential oil in vapour phase 
Microatmosphere plate method was used to screen the anti-Candida activity of C. 
verum leaf oil qualitatively. The protocol used here was the recommended antimicrobial assay for 
highly volatile plant derivatives including volatile essential oils. The results for antifungal 
properties of working solutions of true cinnamon leaf oil against selected seventeen Candida test 
strains are presented in Table 5.2. According to published studies, any zone of inhibition on agar 





growth inhibition of Candida indicates the susceptibility/sensitivity of test strain to C. verum leaf 
oil (Figure 5.1, Table 5.2). 
According to obtained results from this qualitative assay, C. verum leaf oil exhibited 








Figure 5.1: Inhibition zones of (01) C. albicans (ATCC MYA-2876), (02) C. tropicalis (ATCC 750), (03) 
C. dubliniensis (ATCC MYA-646) for true cinnamon (C. verum) leaf oil. 
 
Table 5.2: Results of zone of inhibitions exhibited by planktonic test strains in the presence of working 
concentration (1.046g/ml) C. verum leaf oil. All experiments were done in triplicates. 
Organism Presence/Absence of growth 
inhibition 
Sensitive/Resistant 
01 C. albicans (ATCC MYA-2876) + Sensitive 
02 C. tropicalis (ATCC 750) + Sensitive 








5.2.2 Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal 
Concentration (MFC) 
The essential oil of C. verum leaves was tested on three test strains of Candida, in 
order to determine their inhibitory effect using the CLSI M27-A3 broth micro dilution method. 
Inhibitory activity of C. verum oil was tested with the concentration series starting from 32mg/ml. 
the minimum concentration tested was 0.0156mg/ml. 
MIC results were obtained by visual observation and obtained results as follows 
including results of control experiments with Chlorhexidine digluconate. (Table 5.3) 
 
Table 5.3: Results of MIC and MFC of Candida spp. Experiment was done in triplicates with three 
individual experiments. Chlorhexidine digluconate was used as positive control. 
 
Microorganism 


























1.0 2.0 2.0 1.0 2.0 2.0 
 
True cinnamon leaf oil exhibited both fungistatic and fungicidal activity on the 
planktonic cells of Candida spp. All test strains exhibited MIC of 1mg/ml, MFC of 2 mg/ml with 
MFC/MIC ratio of 2. (Table 5.3). 
C. albicans showed same MIC and MFC values for both C. verum oil and 
Chlorhexidine digluconate (1.0 and 2.0 mg/ml) and MFC value was two times higher than that 





C. tropicalis was more sensitive for chlorhexidine gluconate compared to C. verum 
leaf oil hence Both MIC and MFC values were lower with Chlorhexidine digluconate compared 
to true cinnamon oil. 
C. dubliniensis exhibited same MIC and MFC pattern for both C. verum leaf oil and 
chlorhexidine digluconate.  
Briefly, C. verum exhibited the similar efficacy as Chlorhexidine digluconate on 
planktonic C. albicans (ATCC MYA-2876) and C. dubliniensis (ATCC MYA-646). C tropicalis 
(ATCC 750) was more susceptible for chlorhexidine digluconate compaired to C. verum leaf oil 
(MFC/MIC was two times higher for C. verum leaf oil). 
 
5.2.3 Killing Time Assay  
This experiment determined the minimum time requires for true cinnamon leaf oil (or 
positive control Chlorhexidine digluconate) to eradicate the viable planktonic Candida cells from 
their in vitro culture. 
Killing curves for C. albicans (ATCC MYA-2876) in the presence of C. verum leaf oil 
(0.5, 1.0 and 2.0 mg/ml) and 2.0 mg/ml Chlorhexidine digluconate were presented in Figure 5.2.  
 
According to obtained results, 0.5 mg/ml and 1.0 mg/ml C. verum leaf oil do not kill 
Candida cells completely within 24h test period whereas 2.0 mg/ml kill Candida cells completely 
within 6h. 
2.0 mg/ml Chlorhexidine digluconate has a rapid killing action on Candida cells 









Figure 5.2: Killing curves of C. albicans (ATCC MYA-2876) for 0.5mg/ml, 1.0 mg/ml and 2mg/ml C. 
verum leaf oil and 2.0 mg/ml Chlorhexidine digluconate. (CV: C. verum leaf oil, CHL: Chlorhexidine 
digluconate). All error bars represent the ± 2 standard deviations (SD). 
 
5.3  Initial Adhesion 
Attachment to the host surfaces (followed by biofilm formation) is a virulent factor of 
Candida as well as the first step of microbial biofilm formation. This step consists of two major 
phases, namely initial attachment and irreversible attachment.  
The results of the microtiter plate XTT method in order to determine the effect of C. 






Figure 5.3: Percentage reduction in XTT metabolic activity of C. albicans (ATCC MYA-2876), C. 
tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) in the presence of different concentrations 
of CV: C. verum leaf oil and CHL: Chlorhexidine digluconate. All error bars represent the ± 2 standard 
deviations (SD). 
 
According to obtained data, C. verum leaf oil effectively reduce the adhesion of all test 
strains on to polystyrene surface compared to negative control. C. albicans achieved 50% 
reduction in adhesion with 1.0 mg/ml concentration, whereas, C. tropicalis and C. dubliniensis 
showed 50% reduction in adhesion with >2.0 mg/ml and 0.34 mg/ml concentrations of oil 





tropicalis and C. dubliniensis with the concentrations of 1.06 mg/ml, 0.72 mg/ml and 1.32 mg/ml 
respectively. 
5.4 Effect of C. verum Leaf Oil on Germ Tube Formation 
Germ tube formation is one of the key virulent factors of C. albicans and Candida non-
albicans, C. dubliniensis which enables the absorption of nutrients from host tissues by invading 
them. This experiment determines the effect of Cinnamon leaf oil and chlorhexidine digluconate 
on germ tube formation of C. albicans (ATCC MYA-2876) and C. dubliniensis (ATCC MYA-
646) in vitro. 
Figure 5.4 shows the percentage of germ tube forming cells in the presence of 0.25, 
0.5 and 1.0 mg/ml of true cinnamon leaf oil and chlorhexidine digluconate throughout 6h 
experiment period. 
According to obtained data, both C. verum leaf oil and chlorhexidine digluconate 
significantly reduced the germ tube formation of C. albicans and C. dubliniensis (p<0.05) with all 
tested concentrations. Both true cinnamon leaf oil and chlorhexidine digluconate at 1.0 mg/ml 
(MIC) concentration completely inhibited the germ tube formation of both Candida species 







Figure 5.4: Percentage germ tube formation of (A) C. albicans (ATCC MYA-2876) and (B) C. dubliniensis 
(ATCC MYA-646) with 0.25, 0.5 and 1.0 mg/ml C. verum leaf oil and Chlorhexidine digluconate within 
6h test period with 2h intervals. 0 mg/ml concentration indicates the negative control. All error bars 









5.5 Effect on Candida Biofilm Formation 
Biofilm is a surface attached cells embedded in extracellular polymeric substances 
derived from attached cells and environmental origin. Biofilm formation is a virulent factor which 
causes higher resistant to antimicrobial agents of microbial pathogens. This experiments 
determines the effect of different concentrations of C. verum leaf oil on biofilm formation of 
surface attached C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis 
(ATCC MYA-646). 
 
5.5.1 Minimum Biofilm Inhibitory Concentration of Biofilm Formation 
In this experiment, minimum concentration of C. verum leaf oil required to inhibit the 
biofilm formation by 50% and 75% (compared to negative control) was determined. 
Biomass/viability of formed biofilms in the presence of essential oil was determined using XTT 
viability assay. Figure 5.5 showed the percentage reduction of XTT metabolic activity of forming 






Figure 5.5: Percentage reduction of XTT metabolic activity of C. albicans (ATCC MYA-2876), C. 
tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) forming biofilms with the presence of 
different concentrations of C. verum leaf oil and Chlorhexidine digluconate. All error bars represent the ± 
2 standard deviations (SD). CV: C. verum leaf oil, CHL: Chlorhexidine digluconate. All error bars represent 
the ± 2 standard deviations (SD). 
 
According to obtained data, concentrations required to reduce the biofilm formation 







Table 5.4: Minimum biofilm inhibitory concentrations (MBIC50 and MBIC75) for forming biofilms of C. 
albicans (ATCC MYA-2876),  C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646). CHL: 
Chlorhexidine digluconate. 
 
 C. albicans C. tropicalis C. dubliniensis 
C. verum  CHL C. verum  CHL C. verum  CHL 
50% Reduction 
(mg/ml) 
0.15 0.05 0.35 0.08 0.2 0.025 
75% Reduction 
(mg/ml) 
0.4 0.1 0.6 0.2 0.4 0.065 
 
 
5.5.2 Minimum toxic concentration for forming biofilms (MTC) 
Minimum concentration of C. verum leaf oil required to prevent the biofilm formation 
completely by killing Candida cells was determined using CFU assay. Figure 5.6 represents the 
viability of forming biofilms with the presence of different concentrations of C. verum leaf oil and 
Chlorhexidine digluconate determined by CFU assay for forming biofilms. Table 5.5 represents 































Figure 5.6: Log CFU values of forming CA: C. albicans (ATCC MYA-2876), CT: C. tropicalis (ATCC 
750) and CD: C. dubliniensis (ATCC MYA-646) biofilms in the presence of different concentrations of (A) 








Table 5.5: Concentrations of C. verum leaf oil and Chlorhexidine digluconate that kill the forming biofilms 





Concentration requires to kill the forming biofilms 
(mg/ml) 
C. verum leaf oil Chlorhexidine digluconate 
C. albicans (ATCC MYA-2876) 1.0 0.25 
C. tropicalis (ATCC 750) 1.0 0.125 
C. dubliniensis (ATCC MYA-646) 1.0 0.125 
 
 
1.0mg/ml C. verum kill the forming biofilms of all test strains, C. albicans (ATCC 
MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646). Chlorhexidine 
digluconate kills forming biofilms of Candida species with low concentrations compared to C. 
verum leaf oil. For C. albicans, the killing concentration with Chlorhexidine digluconate was 0.25 
mg/ml (Four times low concentration compared to that value of C. verum leaf oil) and for C. 
tropicalis and C. dubliniensis, killing concentration was 0.125 mg/ml (Eight times less 
concentration compared to that value of C. verum). 
 
5.5.3 Scanning Electron Microscopy (SEM) of forming biofilms 
Ultrastructure of forming biofilms of C. albicans (ATCC MYA-2876), C. tropicalis 
(ATCC 750) and C. dubliniensis (ATCC MYA-646) in the presence of 0.5, 1.0 and 2.0 mg/ml C. 
verum leaf oil, Chlorhexidine digluconate and Fluconazole was qualitatively evaluated by SEM 
(Figure 5.7, 5.8 and 5.9).  
C. verum leaf oil caused the Candida cell shrinkage by damaging the cell wall and 





damage was observed with 2 mg/ml C. verum leaf oil. And C. verum leaf oil reduced the biofilm 
development and biofilm cell density.  
When considering Chlorhexidine digluconate, it exhibited the similar effect as C. 
verum leaf oil (damaging cell walls of Candida cells and cause cytoplasmic leakages). Further, 
according to SEM observations, Chlorhexidine digluconate decreased pseudo hyphae formation 
of C. tropicalis compared to negative control.  
Similar observations were obtained for maturing biofilms of C. albicans (ATCC 
MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) with Fluconazole. 
Biofilms formed in the presence of 0.008 mg/ml Fluconazole exhibited rough cellular surfaces 
indicating cell wall deformities. And there was no noticeable density reduction of sessile cells in 
biofilms formed in the presence of Fluconazole, compared to negative control.  
Extracellular polymeric matrix that is characteristic  of  biofilms  was  not  observed  
in  any  of  the  biofilms analysed using SEM since pre-treatments and electron beam of the 








Figure 5.7: SEM images of C. albicans (ATCC MYA-2876) forming biofilms in the presence of 0.5 mg/ml 
C. verum leaf oil (A and D), 1.0 mg/ml C. verum leaf oil (B and E), 2mg/ml C. verum leaf oil (C and F), 
0.25 mg/ml Chlorhexidine digluconate (G and J) and 0.008 mg/ml Fluconazole (H and K). I and L: Negative 
















Figure 5.8: SEM images of C. tropicalis (ATCC 750) forming biofilms in the presence of 0.5 mg/ml C. 
verum leaf oil (A and D), 1.0 mg/ml C. verum leaf oil (B and E), 2.0 mg/ml C. verum leaf oil (C and F), 
0.25 mg/ml Chlorhexidine digluconate (G and J) and 0.008 mg/ml Fluconazole (H and K) I and L: Negative 














Figure 5.9: SEM images of C. dubliniensis (ATCC MYA-646) forming biofilms in the presence of 0.5 
mg/ml C. verum leaf oil (A and D), 1.0 mg/ml C. verum leaf oil (B and E), 2mg/ml C. verum leaf oil (C 
and F), 0.25 mg/ml Chlorhexidine digluconate (G and J) and 0.008 mg/ml Fluconazole (H and K) I and L: 

















5.5.4 Biofilm Progression Analysis Using Time Lapses Microscope 
Progression of Candida in vitro biofilms with initial microcolony formation, cell 
proliferation and biofilm establishment in the presence of C. verum leaf oil was qualitatively 
visualized using Time Lapse Microscopy imaging technique. 
Figure 5.10 A, B and C indicate the Time lapses microscopic images of forming 
biofilms of C. albicans (ATCC MYA-2876); C. dubliniensis (ATCC MYA-646) and C. tropicalis 
(ATCC 750) without essential oil treatment, 0.5 mg/ml, 1.0 mg/ml and 2.0 mg/ml C. verum leaf 
oil treatment for 24h time period. 
The progression of the untreated (negative) control biofilm demonstrates excessive 
biofilm developement throughout the observation period. 0.5 mg/ml concentration of C. verum 
leaf caused retardation of biofilm development of Candida spp. 1.0 mg/ml and 2.0 mg/ml C. verum 
leaf oil completely inhibited C. tropicalis and C. dubliniensis cell proliferation and biofilm 
development from 0h.  
With 1.0 mg/ml C. verum leaf oil, C. albicans exhibited slight cell proliferation upto 
















Figure 5.10 A: Time Lapses images of developing biofilms of C. albicans (ATCC MYA-2876). Each 
column represents the concentration of C. verum leaf oil treatment.   






Figure 5.10 B: Time Lapses images of developing biofilms of C. tropicalis (ATCC 750). Each column 





    
Figure 5.10 C: Time Lapses images of developing biofilms of C. dubliniensis (ATCC MYA-646). Each 





5.6 Effect on Established Candida Biofilms   
   
5.6.1 Minimum Biofilm Inhibitory Concentration (MBIC50 and MBIC75)   
Minimum concentrations of the essential oil required to reduce the biofilm cell   
viability by 50% and 75% of viability of negative control biofilms (biofilms without treatments) 
were defined as MBIC50 and MBIC75. MBIC50 and MBIC75were determined by treating 24h 
mature biofilms with different concentrations of C. verum leaf oil followed by XTT viability 
assay.   
Figure 5.11 shows the percentage reduction of biofilm cell viability of 24h mature C.   
albicans (ATCC MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) 
biofilms determined by XTT viability assay after 24h treatment with C. verum leaf oil compared 
to negative control (biofilms without treatment).    





   
  
Figure 5.11: Percentage reduction of XTT metabolic activity of C. albicans (ATCC MYA-2876), C. 
tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) 24h established biofilms after treatment 
with different concentrations of C. verum leaf oil and Chlorhexidine digluconate. All error bars represent 
the ± 2 standard deviations (SD). CV: C. verum leaf oil, CHL: Chlorhexidine digluconate.   
   
According to obtained data from XTT assay, concentrations required to reduce the   
biofilm viability by 50% and 75% as follows (Table 5.6).   
   








Table 5.6: Minimum biofilm inhibitory concentrations (MBIC50 and MBIC75) for established biofilms of 
C. albicans (ATCC MYA-2876),  C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646). CHL:  
Chlorhexidine digluconate.   
 
   C. albicans   C. tropicalis   C. dubliniensis   
C. verum    CHL   C. verum    CHL   C. verum    CHL   
MBIC50 (mg/ml)   0.1   0.2   0.2   0.0625   0.2   0.3   
MBIC75 (mg/ml)   0.5   0.4   0.9   0.3   1.2   0.4   
   
5.6.2 Minimum Biofilm Eradication Concentration (MBEC)   
Minimum concentration of C. verum leaf oil required to kill the 24h mature biofilm   
completely (MBEC) was determined using CFU assay. Figure 5.12 represents the viability of 
24h mature biofilms after treating different concentrations of C. verum leaf oil and Chlorhexidine 
digluconate for 24h determined by CFU assay. Table 5.7 shows MBEC values for mature C. 
albicans (ATCC MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) 
biofilms.   
   
   





    
Figure 5.12: Log CFU values of forming C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750) and 
C. dubliniensis (ATCC MYA-646) biofilms in the presence of different concentrations of CV: C. verum 
leaf oil and CHL: Chlorhexidine digluconate. All error bars represent the ± 2 standard deviations (SD).   
   
Table 5.7: Concentrations of C. verum leaf oil and Chlorhexidine digluconate that kill the established 
biofilms of C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC 









   
Test strain   
Concentration requires to kill the forming biofilms   
(mg/ml)   
C. verum leaf oil   Chlorhexidine digluconate   
C. albicans (ATCC MYA-2876)   2.0   1.0   
C. tropicalis (ATCC 750)   2.0   4.0   
C. dubliniensis (ATCC MYA-646)   2.0   4.0   
   
   
5.6.3 Scanning Electron Microscopy (SEM) of established biofilms   
Ultrastructure of established biofilms of C. albicans (ATCC MYA-2876), C. tropicalis   
(ATCC 750) and C. dubliniensis (ATCC MYA-646) after treating with 1.0, 2.0 and 4.0 mg/ml of 
C. verum leaf oil, 1 mg/ml (for C. albicans biofilms), 4.0 mg/ml (for C. tropicalis and C. 
dubliniensis biofilms) Chlorhexidine digluconate and 0.008 mg/ml Fluconazole was qualitatively 
evaluated by SEM (Figure 5.13, 5.14 and 5.15).    
C. verum leaf oil showed the Candida cell shrinkage by damaging walls of mature   
sessile cells, pseudohyphae and hyphae and cause leakage of intracellular materials. These effects 
were concentration dependent. Maximum cell damage was observed with 4 mg/ml of C. verum 
leaf oil. Both 2 mg/ml and 4 mg/ml of C. verum leaf oil showed complete destruction of 24h 
mature biofilms of C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750) and C. 
dubliniensis (ATCC MYA-646) with 24h treatment.   
When considering Chlorhexidine digluconate, it exhibited the similar effect as C.   
verum leaf oil (damaging cell walls of Candida cells and cause cytoplasmic leakages) of 
established Candida biofilms.    
Similar observations were obtained for 24h established biofilms of C. albicans 
(ATCC MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) with 
0.008 mg/ml Fluconazole. Biofilms treated with 0.008 mg/ml Fluconazole exhibited rough 
cellular surfaces indicating that cell wall deformities and leakages of intracellular components 





Extracellular polymeric matrix was not observed in any of the biofilms analysed   
using SEM since pre-treatments and electron beam of the equipment may cause destruction of 
the matrix.   






   
Figure 5.13: SEM images of C. albicans (ATCC MYA-2876) established biofilms after 24h treating with 
1.0 mg/ml C. verum leaf oil (A and D), 2.0 mg/ml C. verum leaf oil (B and E), 4mg/ml C. verum leaf oil  
(C and F), 1.0 mg/ml Chlorhexidine digluconate (G and J) and 0.008 mg/ml Fluconazole (H and K). I and 
L: Negative control.       – Cell wall deformities with treatments.          –       Leakages of intracellular 






   
Figure 5.14: SEM images of C. tropicalis (ATCC 750) established biofilms after 24h treatment with 1.0 
mg/ml C. verum leaf oil (A and D), 2.0 mg/ml C. verum leaf oil (B and E), 4.0 mg/ml C. verum leaf oil (C 
and F), 4.0 mg/ml Chlorhexidine digluconate (G and J) and 0.008 mg/ml Fluconazole (H and K) I and L:   
Negative control.      – Cell wall deformities with treatments.                
   






   
Figure 5.15: SEM images of C. dubliniensis (ATCC MYA-646) established biofilms after 24h treatment 
of 1.0 mg/ml C. verum leaf oil (A and D), 2.0 mg/ml C. verum leaf oil (B and E), 4.0 mg/ml C. verum leaf 
oil (C and F), 4.0 mg/ml Chlorhexidine digluconate (G and J) and 0.008 mg/ml Fluconazole (H and K) I 
and L: Negative control.       – Cell wall deformities with treatments. –  - Leakages of intracellular 
components.   






5.7 Transmission Electron Microscopy (TEM)    
Post-exposure cellular morphology of planktonic C. albicans (ATCC MYA-2876); C.   
dubliniensis (ATCC MYA-646) and C. tropicalis (ATCC 750) was determined using TEM.    
TEM images of test strains after 24h exposure to MIC of C. verum leaf oil and   
chlorhexidine digluconate were obtained as follows. (Figure 5.16)   
 
 
Figure 5.16: Transmission Electron Microscopic (TEM) images of C. albicans (A, B and C); C. tropicalis 
(D, E and F) and C. dubliniensis (G, H and I). White arrows indicate intra-cellular vacuoles, red circles 
indicate cell wall damages and red solid arrows indicate cytoplasmic coarse granular inclusion bodies. C, 






5.8 Effect of C. verum Leaf Essential Oil on Host Tissues   
   
5.8.1 In vitro cytotoxicity of C. verum leaf oil (HaCaT human keratinocyte cell line)   
In vitro antiproliferative/cytotoxic effect of C. verum leaf oil and chlorhexidine   
digluconate on human cells was determined using immortalized human keratinocytes (HaCaT).   
Post-treatment cellular viability of cell line after treating with different concentrations   
of essential oil was quantified using MTT metabolic assay.    
Figure 5.17 shows the percentage growth inhibition after treatment with different concentrations.    
   
    
Figure 5.17: Percentage of average cellular inhibition of HaCaT cell line after 24h treatment with different 
concentrations of C. verum leaf oil and Chlorhexidine digluconate. All error bars represent the ± 2 standard 







   
5.8.2 In vivo toxicity of C. verum leaf oil (Galleria mellonella larvae)   
In vivo toxicity of C. verum leaf essential oil was evaluated by using in vivo model of   
larvae of Galleria mellonella after treatment with different concentrations of essential oil. The 
test groups were treated with 0.5 mg/ml, 1.0 mg/ml, 2.0 mg/ml and 16 mg/ml of C. verum leaf 
essential oil and later its mortality was recorded for 5 days.   
Figure 5.18 represents the survival rate of the larvae in each concentration to which they were 
exposed. All concentrations tested showed 100% survival of the treated larvae throughout whole 
experiment period.    
    
Figure 5.18: Survival rate of G. mellonella larvae after administration of C. verum leaf oil over 5 days 






Cinnamon has been used as a common culinary spice in several communities for 
centuries. Additionally, cinnamon has been employed as a folk medicine and phytomedicinal 
alternative in different cultures. Basically two species of genus Cinnamomum along with its some 
wild species are commonly using as approved herbal medicine. They are C. verum (True 
Cinnamon/Ceylon Cinnamon) and C. cassia (Chinese Cinnamon). The bark, flowers, fruits and 
leaves of above species comprise of useful medicinal properties (Gruenwald et al., 2010; 
Ranasinghe et al., 2013).The present study was conducted to find out the efficacy of C. verum/ 
true cinnamon leaf oil as a potential phytomedicinal therapeutic alternative against three 
commonest Candida strains, namely C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750) 
and C. dubliniensis (ATCC MYA-646). 
Though anti-bacterial activity of C. verum bark essential oil is well documented, this 
research fills the deficiency in scientific evidences on antimicrobial activity and anti-candida 
activity of C. verum leaf essential oil as well as its effect on host tissues. 
The current study assessed the chemical composition of true cinnamon leaf oil using 
HP-6890 gas chromatograph coupled with HP-5975 selective mass detector. The most abundant 
chemical component was Eugenol (77.22%) followed by Benzyl benzoate (4.53%), Trans 
caryophyllene (3.39%), Acetyle eugenol (2.75%) and Linalool (2.11%). Trans-Cinnamaldehyde 
(1.69%), Acetic acid cinnamyl ester (1.49%) were identified as minor compounds in C. verum leaf 
oil. Previous study carried out by Schmidt et al. (2006) assessed the essential oil extracted from 
leaves of C. verum from Sri Lanka and identified the chemical components as follows: 74.9% 
Eugenol, 4.1% β-caryophyllene, 3% benzyl benzoate 2.5% linalool as main compounds. Eugenyl 
acetate (2.1%), cinnamyl acetate (1.8%), safrole (1.3%) and cinnamaldehyde (1.1%) were 
contained as minor compounds (Schmidt et al., 2006).  Another research carried out by Jantan et 
al. (2008) observed relatively high amounts of eugenol (90.2%) and low amounts of 
β−Caryophyllene (2%) and β-Phellandrene (0.5%) as key components (Jantan et al.,2008). Results 
for GC-MS analysis of C. verum leaf oil obtained in currents study was parallel to the observations 
of Schmidt et al. (2006).   Though all above studies used same species (C. verum) and same part 
of the tree (leaves) to extract essential oil, the different chemical composition of the extracts were 





et al., 2006). On the other hand, comparative analysis chemical composition of C. verum and 
Cassia cinnamon (C. cassia) leaf oil was carried out by wang et al. (2009)  and they observed  
trans-Cinnamaldehyde (30.36%), o-Methoxy-cinnamaldehyde (25.39%), 3-Methoxy-1,2-
propanediol (29.3%) and Coumarin (6.36%) as basic phytochemical components (Wang et al., 
2009). The relatively low amount of cinnamaldehyde and coumarin in C. verum is responsible for 
its characteristic soft aroma and low toxicity on human body (Abraham et al., 2010). However, all 
studies identified Eugenol as key chemical component of cinnamon leaf oil and it is considered as 
the antimicrobial active compound which acts on microbial cell wall.  
In the present study, observations obtained from microatmospheric plate method, 
demonstrated anti-Candida activity of C. verum leaf oil vapor. All three test strains exhibited a 
zone of growth inhibition with the administration of C. verum oil vapor (Table 5.1). Since, in 
normal body temperature, C. verum leaf oil is a vapor, it is important to evaluate the efficacy of 
antimicrobial agent when it is not directly contact with the affected areas. Further, in traditional 
Ayurveda therapy, “Nasya Karma” is a basic treatment method where medications are introduced 
as a vapor inhalation specially for treatment of respiratory tract infections (Gupta et al., 2009). So 
this step can be consider as a screening test for anti-Candida activity of C. verum leaf oil in its 
vapor phase. In addition to that, routine antimicrobial screening tests were carried out using agar 
well diffusion or disk diffusion techniques. Though, these methods show reliable results with non-
volatile antimicrobial substances, they provide erroneous results with highly volatile substances. 
Micro atmospheric plate method is recommended to prevent this error during the assay (Şerban et 
al. 2011). 
Published literatures demonstrate differences on antimicrobial activity in direct contact 
liquid phase and its vapor phase. Lopez et al. (2007) observed a poor antimicrobial inhibitory effect 
of Eugenol in vapor phase compared to its direct contact liquid phase against common food borne 
pathogens. At the same time they observed an equal antimicrobial effect of Eugenol in vapor phase 
and liquid phase on C. albicans (López et al., 2007). Current study also demonstrated a good anti-
Candida effect of vapor phase active compounds which is in agreement with previous data. 
MIC and MFC of C. verum leaf oil on planktonic C. albicans (ATCC MYA-2876), C. 
tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) were determined using CLSI M27-





used as positive control in this experiment. All test strains demonstrated a similar MIC and MFC 
patters with C. verum leaf oil. (MIC 1 mg/ml and MFC 2 mg/ml) and C. albicans (ATCC MYA-
2876), and C. dubliniensis (ATCC MYA-646) showed similar susceptibility pattern for 
chlorhexidine digluconate with MIC of 1mg/ml and MFC of 2mg/ml. On other hand C. tropicalis 
(ATCC 750) exhibited lower and equal MIC and MFC value (0.5mg/ml) with chlorhexidine 
digluconate (Table 5.3). 
Though these data, in principle, demonstrate the antimicrobial action of C. verum leaf 
essential oil with an agreement with already publish data, pointing out that true cinnamon leaf oil 
have an antimicrobial activity due to the presence of bioactive compounds in their essential oil 
(López et al., 2007; Gruenwald et al., 2010; Ranasinghe et al., 2013), MIC and MFC values of 
current study are slightly different from recently published findings. Castro et al. (2013) 
determined MIC and MFC of C. verum blume essential oil using the microdilution technique. 
According to their findings, MIC and MFC of essential oil for C. albicans and C. tropicalis were 
0.3 mg/ml and 2.5 mg/ml (Castro et al. 2013). Another study conducted by Rungel et al. (2018) 
observed 0.25 mg/ml MIC and MFC values of C.verum blume EO on Candida spp. These 
differences in MIC and MFC may be due to the concentration variations of active compounds in 
EO used. According to the classification of activity level of plant materials based on MIC value 
introduced by Duarte et al. (2005), MIC up to 0.5 mg/ml is considered as strong active, 
concentrations from 0.55 to 1.5 mg/ml is considered as moderately active and above 1.5 mg/ml is 
considered as weakly active plant materials against tested microorganisms (Duarte et al., 2005). 
According to this classification, the results obtained with the essential oil of C. verum leaves 
showed moderate anti-fungal activity on tested Candida strains. On the other hand commercial 
antifungal chlorhexidine digluconate exhibited a similar anti-Candida action as C. verum leaf oil 
for C.albicans and C. dubliniensis by demonstrating MIC value of 1 mg/ml. This is an important 
finding when the nontoxic or low toxic, cost effective antimicrobial phytomedicinal agents 
discovery is concerned.  
 As well as minimum effective concentrations, time requires to completely 
eradicate/kill the microbial population is one of the key determinant of antimicrobial potency of a 
given antimicrobial agent and plays a major role in designing the dosage regime of a given 





antifungal Chlorhexidine digluconate was determined using the standard procedure introduced by 
Tsuji et al. (2008). Standard cell suspension of reference strain of C albicans was mixed with MIC 
(1mg/ml), half of MIC (0.5mg/ml) and twice of MIC (2mg/ml or MFC) of the oil dilutions. At 
each time point sample of above mixtures were subjected to CFU assay to determine the viable 
cell count. Results obtained from killing time assay of C. verum leaf essential oil on test strain 
exhibited concentration dependent killing time. MFC (2.0 mg/ml) of C. verum kills C. albicans 
within 6h whereas 2.0 mg/ml Chlorhexidine digluconate kills C. albicans within 1h. Sub-MFC 
concentrations of C. verum EO does not exhibit any fungicidal effect within 24h experiment 
period. (Figure 5.2) Since killing time is concentration dependent, shorter killing times can be 
acquired by increasing the concentration of EO, but the toxicological assessments should be 
contemplated. Though killing time is considered as an essential component of antimicrobial 
profile, there is no evidence based data on time-kill kinetics of C. verum leaf EO on Candida spp. 
Present study fills this deficiency of available data with in vitro experimental design performed on 
ATCC type Candida strains.  
Candida spp. displays many virulent factors that contribute to successfully colonize in 
host tissues. Adhesion to host surfaces (which is the initial step of biofilm formation), germ tube 
formation, biofilm formation and secretion of proteinases and other hydrolytic enzymes and 
aldehyde production are some of them (Calderone et al., 2001). In the current study, the effect of 
C. verum EO on Candida adhesion to polystyrene surfaces was evaluated by inoculating 96 well 
sterile flat bottomed microtiter plates with the 1:1 mixture of standard cell suspensions of reference 
Candida strains and different concentrations of EO. After allowing Candida cells to adhere on to 
polystyrene surface for 2h, adhered cell mass was quantified using XTT metabolic assay (Raut et 
al., 2013). C. albicans achieved 50% reduction in adhesion with 1.0 mg/ml concentration, whereas, 
C. tropicalis and C. dubliniensis showed 50% reduction in adhesion with >2.0 mg/ml and 0.34 
mg/ml concentrations of oil respectively. Reference antifungal Chlorhexidine digluconate 
exhibited 50% of reduction in adhesion to C. albicans, C. tropicalis and C. dubliniensis with the 
concentrations of 1.06 mg/ml, 0.72 mg/ml and 1.32 mg/ml respectively (Figure 5.3). Importantly, 
50% reduction of adhesion on C. albicans and C. dubliniensis was achieved with lower 
concentrations of C. verum leaf oil compared to chlorhexidine digluconate control which indicates 
the higher efficacy of C. verum EO in adhesion reduction of those two strains. According to data 





but the observation may be due to killing of organisms completely during test period (2h). Since 
adhesion on to the host surfaces is one of the major virulent factor and initial step of biofilm 
formation, the anti-adhesion properties of C. verum EO on Candida spp. contributes to its’ aptness 
as an antimicrobial agent.   
Germ tube formation is another major virulent factor of C. albicans and C. dubliniensis 
which enables the absorption of nutrients from host tissues by invading them. Effect of C. verum 
EO on germ tube formation was determined by mixing dilutions of oil with C. albicans and C. 
dubliniensis standard cell suspensions prepared in FBS followed by counting the number of 
germinated cells at 2h, 4h and 6h experiment period. At sub-MIC (0.25 and 0.5 mg/ml), both C. 
verum leaf oil and chlorhexidine digluconate significantly reduces the germ tube formation of both 
C. albicans and C. dubliniensis whereas MIC (1.0 mg/ml) completely inhibit the germ tube 
formation of test strains (Figure 5.4). With time (for C. albicans, after 2h and for C. dubliniensis, 
after 4h) the germ tube formation in all groups including control group gradually decreased since 
produced germ tubes transformed to pseudo hyphae and hyphae. There are no published scientific 
evidences available on effect of true cinnamon leaf EO on adhesion and germ tube formation of 
Candida spp. Current study was designed to find the efficacy of Cinnamon leaf oil on controlling 
virulent factors of Candida spp. in order to fill this gap of available data. Adhesion and germ tube 
formation are key attributes of infection causing ability of Candida and therefore antimicrobial 
substances which interfere with these factors are considered as potential anti-Candida agents. 
Hence C. verum leaf EO can be developed as a therapeutic alternative against Candida infections. 
Biofilm is a surface attached microbial communities embedded in an extracellular 
matrix derived from cells and environment (Acker et al., 2014). Biofilms are more resistant to 
physical and chemical stresses compared to their planktonic counterpart as biofilms exhibit various 
mechanisms to neutralize those external stresses. Extracellular biofilm matrix acts as a physical or 
chemical barrier for diffusion of antimicrobial agents into the biofilm. Further, with the limited 
availability of nutrients, the biofilm community shifts towards slow or no growth status from 
exponential growth. All above factors and induction of a biofilm phenotype and quorum sensing 
contribute to high resistance to antimicrobial agents of a biofilm (Simões et al., 2010; Mah et al., 
2001). Since the resistance of biofilms to available antimicrobial strategies is becoming more 





effective treatment options. In the current study, efficacy of C. verum leaf EO as a potential 
phytomedicinal agent was evaluated on forming biofilms and 24h established Candida biofilms.  
96 well sterile flat bottomed microtiter plates were seeded with the standard cell suspensions of C. 
albicans (ATCC MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) 
and adhered cells were then allowed to form biofilms in the presence of different concentrations 
of C. verum leaf EO. After 24h, viable biomass of formed biofilms were quantified using XTT 
viability assay. Similarly, biofilms of test strains were prepared in sterile 96 well flat bottomed 
microtiter plates and treated with different oil concentrations. Post-treatment biofilm viability was 
quantified using XTT assay. Viability of treated biofilms was further evaluated by performing the 
CFU assay on exposed biofilms.   C. verum EO exhibited a potential antibiofilm effect on forming 
biofilms of C. albicans (ATCC MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC 
MYA-646) test strains. Concentrations required to reduce the biofilm development by 75% 
(Compared to negative control) were ̴ 0.4, 0.6 and 0.4 mg/ml for three test strains respectively. 
And the concentrations of EO required to completely kill the forming biofilms (MTC) were 1.0 
mg/ml for all test strains. Chlorhexidine digluconate kills Candida forming biofilms with lower 
concentrations than C. verum leaf oil (four times lower concentration for C. albicans and eight 
times lower concentration for C. tropicalis and C. dubliniensis) (Table 5.5). Importantly, these 
MTC values are lower than MIC and MFC values of test strains which indicates the high potency 
of killing of forming biofilms of C. verum EO. These data suggest the potential action of true 
cinnamon oil on interrupting the normal process of formation of Candida biofilms. Biofilm 
progression under chemical stress with C. verum leaf oil was visualized with time lapses 
microscope and results obtained from this experiment confirm above observation. 2×MTC (2 
mg/ml) of C. verum EO completely inhibited biofilm development of all test strains from time 0h 
whereas slight cellular proliferation and biofilm development was observed in progressing C. 
albicans with MTC (1 mg/ml) from 0h to 8h. After 8h, no visible biofilm development was noted 
in C. albicans developing biofilms (Figure 5.10 A, B and C). C. tropicalis and C. dubliniensis 
biofilm development was completely inhibited at 0h by MTC. Sub-MTC (0.5 mg/ml) causes 
retardation of biofilm development of all tested Candida strains. These results indicate the possible 
effective use of C. verum leaf EO as a biofilm preventive strategy. Kaneko et al. (2013) analyzed 
real-time Time-Lapse microscopy images to reveal the development process and to calculate the 





the progression of Candida biofilm under treatment with the essential oil, demonstrating that the 
effect of C. verum leaf EO on Candida biofilm development is dose dependent. 
Effect of true cinnamon leaf essential oil do not limit only to planktonic and developing 
biofilms. It kills established Candida biofilms and present study quantified this effect using XTT 
metabolic activity. 75% reduction in cell viability (compared to negative control) of C. albicans 
(ATCC MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) was 
observed with 0.5, 0.9 and 1.2 mg/ml EO respectively (Table 5.6). MBEC of C. verum leaf oil 
against Candida established biofilms was 2.0 mg/ml for all test strains (Table 5.7). These values 
are higher than that values of forming biofilms, which indicates higher resistance to chemical stress 
of mature biofilms.  
SEM images were taken to understand the structure of biofilms developed under EO 
chemical stress and the structure of established Candida biofilms after EO treatment. All biofilms 
of test strains exhibited cell wall damages, cell wall deformities and leakages of intracellular 
materials with treatment of C. verum leaf oil (Figure 5.7, 5.8, 5.9, 5.13, 5.14 and 5.15). 
Importantly, SEM images confirm the dose dependent nature of effects of C. verum leaf essential 
oil. Fluconazole is the known antifungal agent which belongs to azole group and inhibits synthesis 
of fungal sterol, ergosterol (Richardson et al., 1990). On the other hand Chlorhexidine digluconate 
is a biguanide which is used as an antibacterial mouth rinse. It alters the morphology cells and 
damages the cell wall of microorganisms and releases intracellular components. It has been 
suggested as a well-known therapeutic antifungal agent for oral candidiasis (Da Silva et al., 2011 
and Bobichon et al., 1987). Since both antimicrobial agents have an effect on Candida cell wall, 
ultrastructure of forming Candida biofilms with 0.25 mg/ml Chlorhexidine digluconate (for C. 
albicans), 0.125 mg/ml Chlorhexidine digluconate (for C. tropicalis and C. dubliniensis) and 0.008 
mg/ml Fluconazole (maximum recommended in vitro assay concentration, CLSI) were also 
visualized. Similar observations were obtained with the exposure to MTC of Chlorhexidine 
digluconate and 0.008 mg/ml Fluconazole. The intensity of the post-exposure response of 
Fluconazole was minimal due to low concentration. Similar observations to present study were 
obtained by Bennis et al. (2004) and Braga et al. (2007) after treatment of Candida established 
biofilms with Eugenol. According to their observations with SEM, Eugenol treatment induce 





significantly reduced the number of normal yeast and increased that of damaged cells with rough 
and wrinkled surfaces. These effects were also concentration dependent. Current study is in an 
agreement with already published data and suggestive of Eugenol as the antimicrobial active 
compound of true cinnamon leaf EO. 
To confirm the SEM observations with cell wall damages, and to evaluate the 
intracellular/morphological changes of unicellular yeast forms, TEM images of C. albicans 
(ATCC MYA-2876), C. tropicalis (ATCC 750) and C. dubliniensis (ATCC MYA-646) test strains 
were taken after treatment with MIC of C. verum leaf oil. TEM images demonstrated cell wall 
damages and leakages of intracellular compartment (Figure 5.16). Importantly, TEM images 
revealed post-exposure cytoplasmic changes including intracellular vacuoles formation, scattered 
cytoplasm and formation of cytoplasmic granular inclusion bodies. These changes are suggestive 
of chemical stress on Candida cells by C. verum leaf oil. 
All above experiments determined the pharmacodynamics (antimicrobial/anti-
Candida properties) of C. verum leaf oil on Candida. Pharmacodynamics on host tissues was 
evaluated using two experimental models, in vitro cell culture model of human non-cancer 
keratinocytes (HaCaT) cell line and in vivo Galleria mellonella larvae. Those toxicology 
assessments provide proper understanding on effective, nontoxic dose and help in dose regimen 
designing by integrating both pharmacodynamics and pharmacokinetics of C. verum leaf oil. 
Further there are lack of published data on toxicology studies of C. verum leaf oil and current study 
fill that deficiency. 
The half maximal inhibitory concentration (IC50) quantitatively measure how much of 
a particular drug or other substance (inhibitor) is needed to inhibit a given biological process (or 
component of a process) by half (Serra et al., 2018). In current study, in vitro HaCaT cell line was 
employed to determine the in vitro cytotoxicity assessment and determine the IC50 of C. verum 
leaf EO against human cells. Cells were grown in 96 well sterile flat bottomed microtiter plates 
and treated with different concentrations of C. verum leaf oil. Viability of cells after treatment was 
quantified using MTT metabolic assay. The maximum concentration tested was 1000 mg/ml (neat 
concentration of true cinnamon leaf EO oil/ oil without diluting) and this concentration did not 





indicates that the safe use of C. verum leaf EO up to 1000 mg/ml without any toxic effect on human 
cells.   
It is very important that compounds intended for use as therapeutic agent on human 
are adequately tested in suitable animal model systems. Usually Rodents (rabbits, rats and mice) 
are commonly used in this regard, but cost and ethical aspects have to be carefully considered. It 
is therefore useful to contemplate alternative simple experimental models. The Galleria mellonella 
(greater wax moth) larval stage is an immature life stage of an insect and it have been used for 
virulence and antimicrobial efficacy studies previously. There are number of benefits of use of G. 
mellonella larvae including easy to obtain pharmacokinetic and pharmacodynamic data, similar 
microbial pathogenicity and virulence determinants to humans and mice, short life span, smaller 
in size, low cost and without the need of specialized equipment and training and importantly 
functional and structural similarities of to the insect immune system to mammalian innate immune 
system make Galleria mellonella larvae (Ignasiak et al., 2017; Benaducci et al., 2016). Current 
study used G. mellonella larvae in vivo model to determine the lethal concentration (LC) of C. 
verum EO. 
Different concentrations of EO were introduced to study population of G. mellonella 
larvae and kept the study model at 37 oC for five days under observation. In this experiment, 100% 
survival was observed with G. mellonella larvae after administration of all test concentrations 
ranging from 0.5 to 1000 mg/ml C. verum EO. This indicates the zero toxicity of true cinnamon 
leaf oil on test group. Since 1000 mg/ml is the highest possible concentration of C. verum leaf EO 
(neat solution) all dilutions including neat solution can be considered as non-toxic to experiment 
model (Figure 5.18). 
Based on in vitro and in vivo toxicology study results and pharmacodynamics of C. 
verum leaf oil on Candida sessile and planktonic cells, C. verum leaf EO can be considered as a 
potential therapeutic alternative for Candida infections. Also authors suggest future research on 








 C. verum leaf oil contains Eugenol, Acetyle eugenol and Cinnamaldehyde as active 
compounds. 
 C. verum leaf oil vapor has a potential anti-Candida activity on planktonic Candida. 
 True Cinnamon leaf oil demonstrates both Fungicidal and Fungi static activity. 
 True Cinnamon leaf oil negatively affect germ tube formation and adhesion of Candida. 
 C. verum leaf oil exhibits anti biofilm activity on both forming and established C. albicans, 
C. tropicalis and C. dubliniensis. 
 True Cinnamon leaf EO acts on Candida cell wall and causes cell wall damages and cell 
wall deformities. 
 All these effects are concentration dependent. 
  C. verum leaf oil does not exhibit any significant cytotoxicity in HaCaT in vitro cell culture 
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1. Chromatogram of Cinnamon leaf oil 
2. Similarity analysis report 
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Identified chemical compounds of C. verum leaf EO. 
 
tR (min) 
(a) IR (b) Identification % rel. (c) 
5.38 932 Alfa-Pineno 0.81 
5.76 946 Canfeno 0.25 
6.03 957 Benzaldehyde 0.18 
6.50 975 Beta-Pineno 0.23 
7.29 1004 Alfa-Felandreno 0.96 
7.92 1022 Para-Cimeno 0.76 
8.07 1027 Limoneno 0.75 
10.56 1099 Linalol 2.11 
14.16 1189 Alfa-Terpineol 0.28 
17.45 1267 Trans-Cinamaldehyde 1.69 
18.23 1285 Safrol 0.94 
21.41 1361 Eugenol 77.22 
21.92 1374 Alfa-Copaeno 0.60 
23.67 1416 Trans-Caryophylene 3.39 
24.71 1442 Acetic acid cinnamyl ester 1.49 
25.02 1450 α-humulene 0.58 
28.03 1526 Eugenol acetate 2.75 
30.06 1579 Caryophylene oxide 0.46 




Notes: a) Retention Time  
            b) Retention Index 










Annex 2 - Similarity analysis report 
 
